You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Osmitrol Intravenous Infusion (Mannitol Intravenous Infusion, BP) can be used in: The promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; The reduction of intraocular pressure when the pressure cannot be lowered by other means; The reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; Promoting the urinary excretion of toxic substances.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Osmitrol Intravenous Infusion (Mannitol Intravenous Infusion, BP) can be used in: The promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; The reduction of intraocular pressure when the pressure cannot be lowered by other means; The reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; Promoting the urinary excretion of toxic substances.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Osmitrol Intravenous Infusion (Mannitol Intravenous Infusion, BP) can be used in: The promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; The reduction of intraocular pressure when the pressure cannot be lowered by other means; The reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; Promoting the urinary excretion of toxic substances.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Osmitrol Intravenous Infusion (Mannitol Intravenous Infusion, BP) can be used in: The promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; The reduction of intraocular pressure when the pressure cannot be lowered by other means; The reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; Promoting the urinary excretion of toxic substances.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
